BIO SB Products and Technology for Molecular Pathology
Bio SB performs R&D, production, distribution and marketing of unique products for Immunohistochemistry (IHC), Immunocytochemistry (ICC), Fluorescent in situ hybridization (FISH), Chromogenic in situ hybridization (CISH), Liquid-Based Cytology (LBC) and Polymerase Chain Reaction (PCR) technologies that meet the highest international standards for applications in Molecular Pathology, Cancer Research, Microbiology, Immunology and Genetics. BIO SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP and ISO 13485:2003 standards. These guidelines enable us to produce an IVD product that meets the highest in vitro diagnostic standards.
|Dec. 3-7||Bio SB to attend CSP in San Francisco||Events|
|Nov. 9||bcd-6 Rabbit Monoclonal Press Release||Link|
|Sept. 9th||Hydrophilic Plus Slides featured in MLO||Link|
|Sept. 9th||Bio SB & Cancer Diagnostics Announce Partnership||Link|
|June 11th||HRP Green Announced||Link|
|March 4th||Bio SB Debuts the Automated TintoStainer at USCAP 2013||Link|